SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Valiant Laboratories - Quaterly Results

06 Nov 2023 Evaluate
The sales slipped to Rs. 595.47 millions, down -32.30% for the September 2023 quarter as against Rs. 879.58 millions during the year-ago period.Net Profit for the quarter ended September 2023 dipped to Rs. 7.94  millions from Rs. 86.59 millions  in the corresponding previous quarter.A decline of 15.73 millions was observed in the OP in the quarter ended September 2023 from 121.51 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202309 202209 % Var
Sales 595.47 879.58 -32.30 595.47 879.58 -32.30 595.47 879.58 -32.30
Other Income 29.59 14.67 101.70 29.59 14.67 101.70 29.59 14.67 101.70
PBIDT 15.73 121.51 -87.05 15.73 121.51 -87.05 15.73 121.51 -87.05
Interest 0.19 1.70 -88.82 0.19 1.70 -88.82 0.19 1.70 -88.82
PBDT 15.54 119.81 -87.03 15.54 119.81 -87.03 15.54 119.81 -87.03
Depreciation 4.90 3.67 33.51 4.90 3.67 33.51 4.90 3.67 33.51
PBT 10.64 116.14 -90.84 10.64 116.14 -90.84 10.64 116.14 -90.84
TAX 2.70 29.55 -90.86 2.70 29.55 -90.86 2.70 29.55 -90.86
Deferred Tax -2.28 1.18 -293.22 -2.28 1.18 -293.22 -2.28 1.18 -293.22
PAT 7.94 86.59 -90.83 7.94 86.59 -90.83 7.94 86.59 -90.83
Equity 325.60 162.80 100.00 325.60 162.80 100.00 325.60 162.80 100.00
PBIDTM(%) 2.64 13.81 -80.88 2.64 13.81 -80.88 2.64 13.81 -80.88

Valiant Laboratories Share Price

66.03 -0.97 (-1.45%)
22-Apr-2026 10:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1657.45
Dr. Reddys Lab 1212.50
Cipla 1228.00
Zydus Lifesciences 927.55
Lupin 2307.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×